|
Palo Alto, CA, February 26, 2004 — Telik, Inc. (Nasdaq:
TELK) announced its presentation at the Seventh Annual Lehman Brothers
Global Healthcare Conference in Miami Beach, Florida on Wednesday,
March 3, 2004 at 9:00 a.m. Eastern time (6:00 a.m. Pacific time).
A live webcast of the presentation will be accessible at Telik’s
website, www.telik.com. An archive of the webcast will be available
on the Telik website within approximately 24 hours after the presentation
through March 10, 2004.
Telik, Inc. of Palo Alto, CA is a biopharmaceutical company working
to discover, develop and commercialize small molecule drugs to treat
serious diseases for which there is significant demand for new therapies.
The company’s most advanced drug development candidate is
TELCYTA™. Telik’s product candidates were discovered
using its proprietary drug discovery technology, TRAP, which enables
the rapid and efficient discovery of small molecule drug candidates.
Additional information is available at www.telik.com.
###
Contact:
Carol DeGuzman
Senior Director, Corporate Communications
Telik, Inc.
Tel 650-845-7728
Email cdeguzman@telik.com
Go to: 2004
Press Releases2003
Press ReleasesEvents
|
